IRIS
GIALLONGO, CESARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.908
EU - Europa 4.354
AS - Asia 2.947
AF - Africa 504
SA - Sud America 457
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.178
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.727
IT - Italia 1.905
RU - Federazione Russa 1.297
SG - Singapore 1.288
CN - Cina 850
BR - Brasile 371
CI - Costa d'Avorio 331
IE - Irlanda 292
VN - Vietnam 278
FR - Francia 154
KR - Corea 146
UA - Ucraina 142
CA - Canada 117
DE - Germania 117
GB - Regno Unito 101
BD - Bangladesh 78
IN - India 75
FI - Finlandia 63
NG - Nigeria 52
SE - Svezia 52
JP - Giappone 51
SN - Senegal 51
PL - Polonia 48
NL - Olanda 41
MX - Messico 40
HK - Hong Kong 36
AR - Argentina 31
CZ - Repubblica Ceca 27
ES - Italia 26
IQ - Iraq 23
ZA - Sudafrica 19
CH - Svizzera 18
EC - Ecuador 17
BE - Belgio 16
BJ - Benin 16
TR - Turchia 15
LB - Libano 11
AE - Emirati Arabi Uniti 9
CL - Cile 9
ID - Indonesia 9
IL - Israele 9
MA - Marocco 9
UZ - Uzbekistan 9
GR - Grecia 8
KE - Kenya 8
LT - Lituania 8
NP - Nepal 7
PK - Pakistan 7
PY - Paraguay 7
AT - Austria 6
CO - Colombia 6
JO - Giordania 6
TN - Tunisia 6
AU - Australia 5
CR - Costa Rica 5
IR - Iran 5
NI - Nicaragua 5
SA - Arabia Saudita 5
VE - Venezuela 5
AL - Albania 4
EG - Egitto 4
ET - Etiopia 4
HR - Croazia 4
NO - Norvegia 4
PH - Filippine 4
RO - Romania 4
SI - Slovenia 4
BO - Bolivia 3
GT - Guatemala 3
JM - Giamaica 3
KZ - Kazakistan 3
OM - Oman 3
PE - Perù 3
RS - Serbia 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
UY - Uruguay 3
AZ - Azerbaigian 2
DZ - Algeria 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
MY - Malesia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SR - Suriname 2
AM - Armenia 1
BF - Burkina Faso 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
KW - Kuwait 1
MK - Macedonia 1
Totale 14.172
Salva come PNG Salva come JPEG
Città #
Dallas 1.294
Singapore 867
Santa Clara 671
Moscow 654
Catania 499
Chandler 453
San Jose 445
Ashburn 350
Abidjan 330
Chicago 298
Dublin 286
Hefei 227
Jacksonville 157
Beijing 156
Los Angeles 153
Seoul 139
Boardman 123
Lauterbourg 93
Civitanova Marche 91
New York 89
Florence 86
Houston 83
Rome 83
Ho Chi Minh City 77
Council Bluffs 74
Cambridge 68
Lawrence 68
Milan 67
Palermo 67
Andover 64
Buffalo 54
Toronto 52
Dakar 51
Hanoi 50
São Paulo 50
Dong Ket 44
Warsaw 44
Munich 43
Nanjing 42
Des Moines 36
Messina 35
Tokyo 34
Hong Kong 33
Bari 29
Orem 29
Abuja 28
Montreal 27
Bronte 26
Misterbianco 26
Bremen 25
Helsinki 24
Wilmington 24
Amsterdam 23
Lagos 23
Lappeenranta 23
Paris 22
Brooklyn 21
Chennai 21
London 21
Boston 20
Naples 20
The Dalles 20
Brno 19
Saint Petersburg 19
San Mateo 19
Stockholm 19
Denver 18
Falls Church 18
Nanchang 18
Poplar 18
Atlanta 17
Shenyang 17
Turin 17
Washington 17
Cotonou 16
Turku 16
Columbus 15
Brussels 14
Charlotte 14
Dearborn 14
Fukuoka 14
Johannesburg 14
Manchester 14
Mexico City 14
Mumbai 14
San Giovanni la Punta 14
Seattle 14
Augusta 13
Acireale 12
Hebei 12
Kochi 12
Ottawa 12
Phoenix 12
San Francisco 12
Guangzhou 11
Piscataway 11
Changsha 10
Haiphong 10
Mascalucia 10
Aci Catena 9
Totale 9.681
Salva come PNG Salva come JPEG
Nome #
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 280
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 242
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 229
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 228
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 218
Biological properties of itraconazole-SLN 215
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance 212
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 208
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 203
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 201
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing 199
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 197
Clobetasol modulates adult neural stem cell growth via canonical hedgehog pathway activation 190
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 189
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 189
A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells 188
Focus on Osteosclerotic Progression in Primary Myelofibrosis 187
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 182
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib 182
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 181
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 181
Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients 172
Biological properties of itraconazole-SLNs 172
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 166
Hedgehog signaling pathways in multiple myeloma 165
Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells 165
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 164
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients 162
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 160
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 159
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 158
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma 158
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 157
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models 155
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 155
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 154
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential 151
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 149
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 149
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 148
Targeted metabolomic evaluation of peripheral blood mononucleated cells from patients with PMM2-CDG 145
Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype 144
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 144
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 143
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 143
Correction to: Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models (Antioxidants, (2022), 11, 8, (1596), 10.3390/antiox11081596) 142
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 142
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 142
Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells 139
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 139
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 139
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 137
Effect of lipoic acid on the biochemical mechanisms of resistance to bortezomib in SH-SY5Y neuroblastoma cells 135
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 132
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 131
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 130
The Role of Epigenetics in Neuroinflammatory-Driven Diseases 129
Pericytes in microvessels: From “mural” function to brain and retina regeneration 129
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 128
The Heme Oxygenase System in Hematological Malignancies 128
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 128
Nuclear translocation of Heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells 127
Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project 127
Rebalancing Immune Interactions within the Brain-Spleen Axis Mitigates Neuroinflammation in an Aging Mouse Model of Alzheimer’s Disease 126
Correction to: Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 125
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 125
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 123
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 121
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 120
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells 118
Myeloid-derived suppressor cells in Chronic myeloid leukemia 115
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 114
Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors 114
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 111
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 111
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 110
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 104
Neuroactive molecules and growth factors modulate cytoskeletal protein expression during astroglial cell proliferation and differentiation in culture 104
Effects of imatinib mesylate in osteoblastogenesis 102
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 101
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro 98
Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity 91
OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE 90
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 90
MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION 89
Pituitary Adenylate Cyclase-Activating Polypeptide Protects Corneal Epithelial Cells against UV-B-Induced Apoptosis via ROS/JNK Pathway Inhibition 88
GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ARE INCREASED IN MULTIPLE MYELOMA DUE TO IMMUNOLOGICAL DYSREGULATION OF MESENCHYMAL STEM CELLS 86
The Pleiotropic Effects of Fumarate: From Mitochondrial Respiration to Epigenetic Rewiring and DNA Repair Mechanisms 83
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma. 81
Uveal melanoma cells elicit retinal pericyte phenotypical and biochemical changes in an in vitro model of coculture 81
Proteasome inhibitors as a possible therapy for SARS-CoV-2 80
Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients 80
IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH ACUTE LEUKEMIA 79
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome 79
Mesenchymal Stromal Cells (MSC) As Key Players in the Tumor Microenvironment Transformation from MGUS to Myeloma 76
LENALIDOMIDE TREATMENT IS ABLE TO RESTORE REGULATORY T CELLS IN MULTIPLE MYELOMA PATIENTS 75
Monocytic myeloid derived suppressor cells in hematological malignancies 75
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells 74
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients 74
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC) 72
Totale 14.028
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.701
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022653 41 77 10 4 116 26 101 49 51 31 18 129
2022/20231.368 96 112 40 144 111 188 19 237 267 44 71 39
2023/2024928 55 140 39 40 47 203 40 88 4 25 168 79
2024/20252.886 42 456 155 198 522 357 157 136 175 226 242 220
2025/20267.310 417 883 1.051 479 950 1.536 581 175 378 441 246 173
2026/2027111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 14.385